Faron Pharmaceuticals Oy (LON:FARN) Stock Price Up 1.3% - Time to Buy?

Faron Pharmaceuticals Oy (LON:FARN - Get Free Report) traded up 1.3% on Wednesday . The stock traded as high as GBX 200 ($2.55) and last traded at GBX 195 ($2.49). 6,878 shares were traded during mid-day trading, a decline of 85% from the average session volume of 46,174 shares. The stock had previously closed at GBX 192.50 ($2.46).

Faron Pharmaceuticals Oy Trading Down 2.6 %

The stock has a market capitalization of £198.78 million, a P/E ratio of -593.75 and a beta of 0.36. The company has a current ratio of 1.45, a quick ratio of 1.09 and a debt-to-equity ratio of 922.55. The business has a 50-day moving average price of GBX 183.83 and a two-hundred day moving average price of GBX 168.01.

Faron Pharmaceuticals Oy Company Profile

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.